RNA interference in embryonic stem cells and the prospects for future therapies.
In 1998, two distinct and exciting scientific fields emerged which have profoundly shaped the current direction of biomedical research. The discovery of RNA interference (RNAi) and the derivation of human embryonic stem (ES) cells have yielded exciting new possibilities for researchers and clinicians alike. While fundamentally different, aspects from these two fields may be combined to yield extraordinary scientific and medical benefits. Here, we review the prospects of combining RNAi and ES cell manipulation for both basic research and future therapies, as well as current limitations and obstacles that need to be overcome.
Heidersbach
A
A
Diabetes Center, University of California, San Francisco, CA 94143-0525, USA.
Gaspar-Maia
A
A
McManus
M T
MT
Ramalho-Santos
M
M
D000818:Animals; D003131:Combined Modality Therapy; D005544:Forecasting; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends; D006801:Humans; D034622:RNA Interference; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000378:metabolism*